Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Friedland

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Emerging Infectious Diseases|March 6, 2010
Extensively drug-resistant Mycobacterium tuberculosis from aspirates, Rural South AfricaScott K Heysell, Anthony P Moll, Neel R Gandhi, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2008
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individualsSharon B Mannheimer, Nicholas Wold, Edward M Gardner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavirElinore F McCance-Katz, David E Moody, Patrick F Smith, et al.
Annals of Internal Medicine|September 5, 2012
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trialKogieleum Naidoo, Nonhlanhla Yende-Zuma, Nesri Padayatchi, et al.
AIDS and Behavior|January 22, 2022
Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods StudyDini Harsono, Yanhong Deng, Sangyun Chung, et al.
BMC Infectious Diseases|December 8, 2010
Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional studyScott K Heysell, Tania A Thomas, Neel R Gandhi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdineElinore F McCance-Katz, David E Moody, Gene D Morse, et al.
AIDS and Behavior|November 1, 2022
Correction to: Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods StudyDini Harsono, Yanhong Deng, Sangyun Chung, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Emerging Infectious Diseases|March 6, 2010
Extensively drug-resistant Mycobacterium tuberculosis from aspirates, Rural South AfricaScott K Heysell, Anthony P Moll, Neel R Gandhi, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2008
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individualsSharon B Mannheimer, Nicholas Wold, Edward M Gardner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavirElinore F McCance-Katz, David E Moody, Patrick F Smith, et al.
Annals of Internal Medicine|September 5, 2012
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trialKogieleum Naidoo, Nonhlanhla Yende-Zuma, Nesri Padayatchi, et al.
AIDS and Behavior|January 22, 2022
Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods StudyDini Harsono, Yanhong Deng, Sangyun Chung, et al.
BMC Infectious Diseases|December 8, 2010
Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional studyScott K Heysell, Tania A Thomas, Neel R Gandhi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdineElinore F McCance-Katz, David E Moody, Gene D Morse, et al.
AIDS and Behavior|November 1, 2022
Correction to: Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods StudyDini Harsono, Yanhong Deng, Sangyun Chung, et al.
Pageof 11